Okomix eye drops 7.5 ml




Ocomix is a drug used in ophthalmology. Dexamethasone in combination with antimicrobial drugs. Indications for use - inflammatory eye diseases in steroid-sensitive patients in whom the use of corticosteroids is indicated and there is a superficial bacterial infection caused by strains of bacteria sensitive to ciprofloxacin, including inflammatory reactions in the postoperative period.
Warehouse
1 ml of the drug contains: ciprofloxacin hydrochloride - 3.5 mg, calculated on 100% anhydrous substance - ciprofloxacin - 3 mg; dexamethasone - 1 mg calculated on 100% dry substance; excipients: hydroxyethylcellulose; benzalkonium chloride; sodium acetate, trihydrate; glacial acetic acid; sodium chloride; disodium edetate (Trilon B); tyloxapol; boric acid; 1 M sodium hydroxide solution and/or 1 M hydrochloric acid solution; water for injection.Contraindication
Hypersensitivity to dexamethasone, ciprofloxacin, other quinolones or to any of the components of the drug.
Cowpox and chickenpox and other viral infections of the cornea and conjunctiva (except keratitis caused by Herpes zoster).
Fungal diseases of the eye structures or untreated parasitic infections of the eye.
Mycobacterial infections of the eye.
Acute epithelial keratitis caused by Herpes simplex.
Acute untreated bacterial infections.
Vaccination.
Method of application
The standard dose is 1–2 drops in the conjunctival sac of the affected eye 4 times a day. During the first 24–48 hours, the dose may be increased to 2 drops every 2 hours.
As a rule, the course of treatment lasts 7 days.
Application features
Serious cases of acute hypersensitivity to ciprofloxacin may require emergency treatment. Oxygen therapy and airway management should be used as clinically indicated.
The use of Ocomix® should be discontinued at the first sign of skin rash or any other signs of a hypersensitivity reaction.
Pregnant women
It is not recommended to use the drug Ocomix® during pregnancy.
Children
The efficacy and safety of the drug in children have not been established.
Drivers
If blurred vision occurs during instillation, the patient should wait until vision clears before driving or operating machinery.
Overdose
Given the characteristics of the medicinal product intended for topical use, no toxic effects are expected either when used in ophthalmology at the recommended doses or in the event of accidental ingestion of the contents of the vial. Clinical signs and symptoms of overdose may be similar to the side effects observed in some patients (punctate keratitis, erythema, increased lacrimation, eyelid edema and itching).
Side effects
Infections and infestations: barley, rhinitis.
Immune system disorders: hypersensitivity.
Nervous system disorders: dysgeusia, headache, dizziness.
Hearing disorders: earache.
Respiratory system disorders, thoracic and mediastinal disorders, sinus hypersecretion.
Storage conditions
Store in original packaging at a temperature not exceeding 25℃.
Do not freeze! Keep out of reach of children.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.